MNKD Butterfly Strategy
MNKD (MannKind Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.
MNKD (MannKind Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $991.7M, a beta of 1.04 versus the broader market, a 52-week range of 2.23-6.51, average daily share volume of 6.8M, a public-listing history dating back to 2004, approximately 403 full-time employees. These structural characteristics shape how MNKD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.04 places MNKD roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a butterfly on MNKD?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current MNKD snapshot
As of May 15, 2026, spot at $3.08, ATM IV 91.01%, IV rank 14.43%, expected move 26.09%. The butterfly on MNKD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this butterfly structure on MNKD specifically: MNKD IV at 91.01% is on the cheap side of its 1-year range, which favors premium-buying structures like a MNKD butterfly, with a market-implied 1-standard-deviation move of approximately 26.09% (roughly $0.80 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MNKD expiries trade a higher absolute premium for lower per-day decay. Position sizing on MNKD should anchor to the underlying notional of $3.08 per share and to the trader's directional view on MNKD stock.
MNKD butterfly setup
The MNKD butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MNKD near $3.08, the first option leg uses a $2.93 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MNKD chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MNKD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.93 | N/A |
| Sell 2 | Call | $3.08 | N/A |
| Buy 1 | Call | $3.23 | N/A |
MNKD butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
MNKD butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on MNKD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on MNKD
Butterflies on MNKD are pinning bets - traders use them when they expect MNKD to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
MNKD thesis for this butterfly
The market-implied 1-standard-deviation range for MNKD extends from approximately $2.28 on the downside to $3.88 on the upside. A MNKD long call butterfly is a pinning play: it pays maximum at the middle strike if MNKD settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current MNKD IV rank near 14.43% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MNKD at 91.01%. As a Healthcare name, MNKD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MNKD-specific events.
MNKD butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MNKD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MNKD alongside the broader basket even when MNKD-specific fundamentals are unchanged. Always rebuild the position from current MNKD chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on MNKD?
- A butterfly on MNKD is the butterfly strategy applied to MNKD (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With MNKD stock trading near $3.08, the strikes shown on this page are snapped to the nearest listed MNKD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MNKD butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the MNKD butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 91.01%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MNKD butterfly?
- The breakeven for the MNKD butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MNKD market-implied 1-standard-deviation expected move is approximately 26.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on MNKD?
- Butterflies on MNKD are pinning bets - traders use them when they expect MNKD to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current MNKD implied volatility affect this butterfly?
- MNKD ATM IV is at 91.01% with IV rank near 14.43%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.